Vertex Pharmaceuticals
VRTX
VRTX
1,540 hedge funds and large institutions have $110B invested in Vertex Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 173 funds opening new positions, 655 increasing their positions, 514 reducing their positions, and 90 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
4% more funds holding
Funds holding: 1,486 → 1,540 (+54)
0.15% more ownership
Funds ownership: 90.86% → 91.01% (+0.15%)
22% less call options, than puts
Call options by funds: $680M | Put options by funds: $875M
Holders
1,540
Holding in Top 10
33
Calls
$680M
Puts
$875M
Top Buyers
| 1 | +$1.31B | |
| 2 | +$535M | |
| 3 | +$371M | |
| 4 |
Swedbank
Stockholm,
Sweden
|
+$312M |
| 5 |
Goldman Sachs
New York
|
+$310M |
Top Sellers
| 1 | -$1.07B | |
| 2 | -$304M | |
| 3 | -$217M | |
| 4 |
Pictet Asset Management
Carouge,
Switzerland
|
-$204M |
| 5 |
ClearBridge Investments
New York
|
-$158M |